Search research articles
Contact Us
Filters
Showing results (121-130 of 379) with videos related to
Page
of 38
Sort By:
Journal of the National Cancer Institute
|
April 7, 2005
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis
Julia Bohlius, Simon Langensiepen, Guido Schwarzer, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
Kathrin Bauer, Michaela Rancea, Verena Roloff, et al.
Annals of Hematology
|
August 7, 2008
Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
Thomas Elter, Janne J Vehreschild, John Gribben, et al.
Haematologica
|
May 10, 2007
Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018)
Sven Trelle, Orhan Sezer, Ralph Naumann, et al.
Deutsches Arzteblatt International
|
August 29, 2018
Hodgkin Lymphoma in Adults
Paul J Bröckelmann, Dennis A Eichenauer, Tina Jakob, et al.
The Lancet. Oncology
|
August 17, 2013
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
Nicole Skoetz, Sven Trelle, Michaela Rancea, et al.
The Cochrane Database of Systematic Reviews
|
February 17, 2012
Alemtuzumab for patients with chronic lymphocytic leukaemia
Nicole Skoetz, Kathrin Bauer, Thomas Elter, et al.
Onkologie
|
April 21, 2005
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia
Peter Vaupel, Jürgen Dunst, Andreas Engert, et al.
Journal of the National Cancer Institute
|
August 17, 2006
Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma
Frauke Naumann, Olaf Weingart, Eva Kruse, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2007
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group
Andrew Macann, Henning Bredenfeld, Rolf-Peter Müller, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 379) with videos related to
Sort By:
Page
of 38
Journal of the National Cancer Institute
|
April 7, 2005
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis
Julia Bohlius, Simon Langensiepen, Guido Schwarzer, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
Kathrin Bauer, Michaela Rancea, Verena Roloff, et al.
Annals of Hematology
|
August 7, 2008
Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
Thomas Elter, Janne J Vehreschild, John Gribben, et al.
Haematologica
|
May 10, 2007
Bortezomib in combination with dexamethasone for patients with relapsed Hodgkin's lymphoma: results of a prematurely closed phase II study (NCT00148018)
Sven Trelle, Orhan Sezer, Ralph Naumann, et al.
Deutsches Arzteblatt International
|
August 29, 2018
Hodgkin Lymphoma in Adults
Paul J Bröckelmann, Dennis A Eichenauer, Tina Jakob, et al.
The Lancet. Oncology
|
August 17, 2013
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis
Nicole Skoetz, Sven Trelle, Michaela Rancea, et al.
The Cochrane Database of Systematic Reviews
|
February 17, 2012
Alemtuzumab for patients with chronic lymphocytic leukaemia
Nicole Skoetz, Kathrin Bauer, Thomas Elter, et al.
Onkologie
|
April 21, 2005
Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia
Peter Vaupel, Jürgen Dunst, Andreas Engert, et al.
Journal of the National Cancer Institute
|
August 17, 2006
Fifth biannual report of the Cochrane Haematologic Malignancies Group--Focus on multiple myeloma
Frauke Naumann, Olaf Weingart, Eva Kruse, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 15, 2007
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Study Group
Andrew Macann, Henning Bredenfeld, Rolf-Peter Müller, et al.
Page
of 38